QUANTITATIVE ASSESSMENT OF MESENCHYMAL DIFFERENTIATION FOR METASTATIC RISK PREDICTION OF CLEAR CELL RENAL CARCINOMA (CCRCC)

被引:0
|
作者
Vilchez, Daniel
Zhang, Bodong
Sanchez, Alejandro
Sirohi, Deepika
Tasdizen, Tolga
Knudsen, Beatrice
机构
来源
JOURNAL OF UROLOGY | 2023年 / 209卷
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
MP41-13
引用
收藏
页码:E560 / E560
页数:1
相关论文
共 50 条
  • [11] CM-728 as a potential and novel compound for metastatic clear cell renal cell carcinoma (ccRCC) treatment
    Arevalo, Jazmine
    Coll-Iglesias, Laura
    Areny-Balaguero
    Sierra-Ramos, Catalina
    Armas-Capote, Natalia
    McNaughton-Smith, Grant
    Meseguer, Anna
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2019, 125 : 24 - 24
  • [12] Clearseq1-4 classifier in localized and metastatic clear-cell renal cell carcinoma (ccRCC)
    Kinget, L.
    Roussel, E.
    Verbiest, A. T. L.
    Lambrechts, D.
    Boeckx, B.
    Zucman-Rossi, J.
    Couchy, G.
    Caruso, S.
    Baldewijns, M.
    De Wever, L.
    Albersen, M.
    Beuselinck, B.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1222 - S1223
  • [13] The genomic landscape of metastatic clear cell renal cell carcinoma (ccRCC) after treatment with systemic therapy.
    Van Der Mijn, Johannes
    Eng, Kenneth
    Fernandez, Evan
    Oromendia, Clara
    Zhang, Tuo
    Bareja, Rohan
    Ramazanoglu, Sinan
    Vosoughi, Aram
    Gudas, Lorraine J.
    Elemento, Olivier
    Tagawa, Scott T.
    Faltas, Bishoy Morris
    Nanus, David M.
    Beltran, Himisha
    Mosquera, Juan Miguel
    Sboner, Andrea
    Molina, Ana M.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [14] Quantitative gene expression using RT-PCR refines the prediction of recurrence risk in resected T1 clear cell renal cell carcinoma (ccRCC)
    Campbell, S.
    Knezevic, D.
    Maddala, T.
    Novotny, W.
    Zhou, M.
    Aydin, H.
    Elson, P.
    Parodi, L.
    Goddard, A.
    Rini, B. I.
    BJU INTERNATIONAL, 2012, 109 : 3 - 3
  • [15] The utility of using immunohistochemistry in the differentiation of metastatic, cutaneous clear cell renal cell carcinoma and clear cell hidradenoma
    Velez, Moises J.
    Thomas, Courtney L.
    Stratton, Jason
    Bergfeld, Wilma
    Weaver, Joshua
    JOURNAL OF CUTANEOUS PATHOLOGY, 2017, 44 (07) : 612 - 615
  • [16] Expression of erythropoietin and neuroendocrine markers in clear cell renal cell carcinoma (CCRCC)
    Mjones, P.
    Nordrum, I.
    Qvigstad, G.
    Sordal, O.
    Rian, L. L. Martensson
    Waldum, H. L.
    VIRCHOWS ARCHIV, 2017, 471 : S283 - S283
  • [17] Immunobiochemical profile of clear cell renal cell carcinoma (ccRCC): A preliminary study
    Vargova, Daniela
    Dargaj, Jan
    Franova, Sona
    Dohal, Matus
    Luptak, Jan
    Svihra, Jan
    Bris, Lukas
    Grendar, Marian
    Sutovska, Martina
    GENERAL PHYSIOLOGY AND BIOPHYSICS, 2023, 42 (05) : 387 - +
  • [18] Results of a feasibility study of I-124 girentuximab in metastatic clear cell renal cell carcinoma (m ccRCC).
    Keefe, Stephen Michael
    Rosen, Mark Alan
    Robinson, Janelle
    McGibney, Karen
    Marshall, Amy
    Mamtani, Ronac
    Vaughn, David J.
    O'Dwyer, Peter J.
    Haas, Naomi B.
    Pryma, Daniel A.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [19] Identification of Prognostic Biomarkers for Clear Cell Renal Cell Carcinoma (ccRCC) by Transcriptomics
    Zhang, Sihong
    Xu, Xianglai
    Wang, Yelin
    Zhu, Yanjun
    Wang, Jiajun
    Wang, Hang
    Guo, Jianming
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2021, 51 (05): : 597 - 608
  • [20] Transcriptional (mRNA) Profiling in Clear Cell Renal Cell Carcinoma (CCRCC): Comparison of CCRCC to Non-Neoplastic Renal Tissue
    Bastacky, S. I.
    Bastacky, M. L.
    Roy, S.
    Parwani, A. V.
    Dhir, R.
    Lyons-Weiler, M. A.
    Sciulli, C. M.
    Krill-Burger, M.
    Amin, M.
    LaFramboise, W. A.
    LABORATORY INVESTIGATION, 2013, 93 : 196A - 196A